Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat Trials

Clinical trial NCT04184869 · COMPLETED

Trial details

NCT number: NCT04184869
Sponsor: Acrotech Biopharma Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Hematological Malignancies

Start date: 2019-08-05
Primary completion: 2022-12-31
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.